Veröffentlichungen aus dem klinischen Bereich

Benefits and Risks in 1101 Duodenal-Jejunal Bypass Liner (DJBL) Treated Patients – Presented at ADA 2024

November 28, 2024

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

November 28, 2024

American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity

November 28, 2024

Duodenal-jejunal bypass liner for treatment of T2DM and obesity: 4-year outcomes in the first National Health Service (NHS) EndoBarrier service

Dezember 10, 2022

Our data demonstrate that EndoBarrier is highly effective in people with refractory diabesity, with ...

Impact of duodenal-jejunal bypass liner (DJBL) on NAFLD in patients with obesity and type 2 diabetes mellitus

November 22, 2022

Significant effects of DJBL treatment on NAFLD fibrosis and APRI score further suggests protective e...

Joint International Consensus Statement for Ending Stigma of Obesity

März 4, 2020

People with obesity commonly face a pervasive, resilient form of social stigma. They are often subje...

The United Kingdom's first NHS Endobarrier service for advanced diabesity: 1-year outcomes for all 62 treated patients

Januar 7, 2020

EndoBarrier was highly effective in this setting in patients with advanced diabetes and obesity. Giv...

Is Early Reimplantation of the Duodenal–Jejunal Bypass Liner Viable?

März 2, 2019

The aim of this study was therefore to investigate the safety, feasibility and effectiveness of earl...

Impact of Proximal Intestinal Exclusion with EndoBarrier on Key Metabolic Parameters and Cardiovascular Risk in the First NHS-UK EndoBarrier Service

Oktober 2, 2018

In addition to reducing the requirement for insulin and a liver fat biomarker, EndoBarrier treatment...

EndoBarrier®: A Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes

Juli 28, 2018

Obesity associated with diabetes mellitus is a significant worldwide problem associated with conside...

Comparative Efficacy and Safety of the Duodenal-Jejunal Bypass Liner in Obese Patients with Type 2 Diabetes Mellitus: A Case Control Study

Juni 24, 2018

This study provides the largest, so far, hypothesis-generating evidence for a putative positive risk...

EndoBarrier in Type 2 Diabetes/Pre-Diabetes with Obstructive Sleep Apnoea Study- Preliminary Results

Juni 24, 2018

End-OSA trial (ISRCTN:33788132) is an NIHR sponsored research trial, to assess the extent to which p...

UK 1st National Health Service (NHS) EndoBarrier Service: Outcomes in 1st 38 Patients to Reach 6 Months after Device Explant

Juni 24, 2018

Our data demonstrate EndoBarrier as highly effective in patients with refractory diabesity. Maintena...

First Risk-Benefit Data from the Association of British Clinical Diabetologists (ABCD) Worldwide EndoBarrier Registry

Juni 24, 2018

The effects of EndoBarrier therapy on glycaemic control, weight and blood pressure are likely to red...

Cost-Effectiveness Analysis of the EndoBarrier Device in Patients with Type 2 Diabetes

Juni 23, 2018

There are multiple pharmacotherapy options for type 2 diabetes mellitus (T2DM) including injectable ...

EndoBarrier as a Pre Bariatric Surgical Intervention in High-Risk Patients: a Feasibility Study

Juni 9, 2018

Endoscopically placed duodenal-jejunal bypass sleeve (EndoBarrier) has been designed to achieve weig...

Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes

Mai 30, 2018

A total of 1,064 studies were identified, 147 of which were duplicates. After abstract review, 741 s...

Efforts to Resurrect EndoBarrier for Use in Obese With Diabetes

Mai 25, 2018

Medscape article by author Marlene Busko.  

A Randomised Controlled Trial of a Duodenal-Jejunal Bypass Sleeve Device (EndoBarrier) Compared with Standard Medical Therapy for the Management of Obese Subjects with Type 2 Diabetes Mellitus

November 15, 2017

Endoscopically placed duodenal-jejunal bypass sleeve devices, such as the EndoBarrier (GI Dynamics, ...

Weight Reduction and Improvement in Diabetes by the Duodenal-Jejunal Bypass Liner: a 198 Patient Cohort Study

Juli 31, 2017

Treatment with the DJBL in T2DM patients with (morbid) obesity results in improvement in glucose con...